SCHEMBL7906246

SCHEMBL7906246

Fc1ccc([C@@H]2NCCO[C@H]2OCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 16/20 0.81
TP53 P04637 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53
TSHR P16473 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
THPO P40225 1/20 0.53
HSD17B10 Q99714 1/20 0.53
GMNN O75496 1/20 0.52
LMNA P02545 1/20 0.52
PMP22 Q01453 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SCN9A Q15858 1/20 0.44
TACR2 P21452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019985 1.00 TACR1 (0.81) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL4440026 1.00 TACR1 (0.81) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL7506741 0.91 TACR1 (0.81) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL7029562 0.90 TACR1 (0.69) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL264433 0.89 TACR1 (1.00) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL7020109 0.89 TACR1 (1.00) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL7023200 0.89 TACR1 (1.00) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL264432 0.89 TACR1 (1.00) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL7964713 0.89 TACR1 (0.64) TACR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL1532499 0.89 TACR1 (0.64) TACR1TP53CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1080080-A4 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE INC (US) 2001-03-07 EP claimed
EP-1080080-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS Advanced Medicine, Inc. (US) 2001-03-07 EP claimed
WO-1999064000-A9 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE INC (US) 2000-04-20 WO claimed
WO-1999064000-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE, INC. (US) 1999-12-16 WO claimed
EP-1080080-A4 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE INC (US) 2001-03-07 EP disclosed
EP-1080080-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS Advanced Medicine, Inc. (US) 2001-03-07 EP disclosed
WO-1999064000-A9 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE INC (US) 2000-04-20 WO disclosed
WO-1999064000-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE NEUROKININ RECEPTORS ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed